Notably, a recent study, while it reported the depletion of EHD2 to increase the oncogenic traits of BC cell lines in vitro, found low EHD2 expression in breast tumors to specify good prognosis and better chemotherapy response (Shen et al., 2020). The gene discussed is EHD2; the disease is breast cancer.